Morgan Stanley Maintains Underweight on Adient, Lowers Price Target to $32
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Adam Jonas maintains an Underweight rating on Adient (NYSE:ADNT) and lowers the price target from $35 to $32.
May 10, 2024 | 3:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley has maintained its Underweight rating on Adient and reduced the price target from $35 to $32, indicating a bearish outlook on the stock.
The reduction in price target by a reputable analyst like Morgan Stanley suggests a negative outlook on Adient's stock performance in the short term. This could lead to a decrease in investor confidence and potentially lower stock prices.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100